The approval of a new oral postexposure prophylaxis for COVID-19 marks a significant advancement in the disease's prevention ...
The U.S. Food and Drug Administration has approved Shionogi's Xocova (ensitrelvir), an oral antiviral, for postexposure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results